• #IARC2017 – Rapid Advances in Research Will Be Key Focus of Global Ataxia Conference
  • Study Links Diabetes in Friedreich’s Ataxia to More Severe Disease and Disability
  • Chondrial’s CTI-1601, a Potential Therapy for FA, Granted Orphan Drug Status by FDA
  • FDA Confirms mFARS as Chief Measure in Phase 2 Trial of Omaveloxolone as Potential FA Therapy
  • Reata Raised $115.9M to Advance Pipeline Development, Including FA Therapy
  • Researchers Identify 2 Molecules That Boost Frataxin Levels in Friedreich’s Ataxia Animal Models
  • SIRT3 Protein Needed for Supplement to Aid Heart in Friedreich’s Ataxia, Study Suggests
  • MicroRNAs Levels in Blood May Diagnose Friedreich’s Ataxia and Those Patients with Heart Failure, Study Says
  • Researchers Create ‘Heart Cells in a Dish’ to Study FA Heart Disease
  • Increased Protein Modification Causes Heart Disease in Friedreich’s Ataxia Patients, Study Shows
  • Multiple Sclerosis Treatment Holds Promise for Friedreich’s Ataxia Patients, Studies Show
  • Brain May Alter Cerebral Functions to Compensate for Motor Deficits in Friedreich’s Ataxia